Microsimulation Model Predicts Survival Benefit of Radiofrequency Ablation and Stereotactic Body Radiotherapy Versus Radiotherapy for Treating Inoperable Stage I Non–Small Cell Lung Cancer

OBJECTIVE: A subset of patients with stage IA and IB non–small cell lung cancer (NSCLC) is ineligible for surgical resection and undergoes radiation therapy. Radiofrequency ablation (RFA) and stereotactic body radiotherapy are newer potentially attractive alternative therapies. MATERIALS AND METHODS...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tramontano, Angela C., Cipriano, Lauren E., Kong, Chung Yin, Shepard, Jo-Anne O., Lanuti, Michael, Gazelle, G. Scott, McMahon, Pamela M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3722903/
https://ncbi.nlm.nih.gov/pubmed/23617484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2214/AJR.12.8968
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky